Under construction – not a live service
Sign in
Taking people in TürkiyeNo phase

Exercise, lung function and quality of life in people with schizophrenia or bipolar disorder

Measures fitness, breathing and quality of life in adults with schizophrenia or bipolar disorder.

Plain-language title generated from the registry record
Registry title: Effects of Schizophrenia and Bipolar Disorder on Exercise Capacity, Pulmonary Function, and Quality of Life

Key facts

Where
Çankırı, TürkiyeSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 65 who volunteer. It studies exercise capacity, lung function, breathing muscle strength and quality of life in people with schizophrenia or bipolar disorder.

Age
18 to 65 years
Sex
All sexes can join.
Disease stage
The record does not give a stage or severity. The study is about schizophrenia and bipolar disorder.

Main reasons for not taking part

  • Any lung, heart, nerve or bone and joint disease that may affect breathing or exercise capacity
  • Any brain or mental illness other than schizophrenia or bipolar disorder

Read by machine on 12 November 2026.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Source: NCT07306468, who can take part

Where in Türkiye

  • Çankırı Karatekin University, Faculty of Health Sciences, Department of Physiotherapy and RehabilitationÇankırı, TürkiyeContact: Furkan ÖzdemirTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Çankırı Karatekin University
Trial code
NCT07306468
Record updated
29 December 2025
Original description
This observational study aims to evaluate exercise capacity, pulmonary function, respiratory muscle strength, and quality of life in individuals diagnosed with schizophrenia and bipolar disorder. These psychiatric conditions are associated with sedentary lifestyles, metabolic side effects of psychotropic medications, and increased comorbidity risks, all of which may negatively impact physical fitness and respiratory health. By assessing cardiorespiratory endurance, pulmonary parameters (FVC, FEV₁), and respiratory muscle strength in this population, the study seeks to identify physiological limitations and contribute to the development of more effective rehabilitation strategies. The findings may support multidisciplinary approaches to improving physical health and overall quality of life in individuals with severe mental illness.Read full original descriptionShow less

Investigation of Exercise Capacity, Pulmonary Function, Respiratory Muscle Strength, and Quality of Life in Patients Diagnosed With Schizophrenia and Bipolar Disorder

This observational study aims to evaluate exercise capacity, pulmonary function, respiratory muscle strength, and quality of life in individuals diagnosed with schizophrenia and bipolar disorder. These psychiatric conditions are associated with sedentary lifestyles, metabolic side effects of psychotropic medications, and increased comorbidity risks, all of which may negatively impact physical fitness and respiratory health. By assessing cardiorespiratory endurance, pulmonary parameters (FVC, FEV₁), and respiratory muscle strength in this population, the study seeks to identify physiological limitations and contribute to the development of more effective rehabilitation strategies. The findings may support multidisciplinary approaches to improving physical health and overall quality of life in individuals with severe mental illness.

Inclusion: Being volunteer for participation; Being 18 to 65 age.

Exclusion: Having any respiratory, cardiac, neurologic or orthopedic disease which may affect respiratory functions or exercise capacity; Having any neuropsychiatric disease except schizophrenia or bipolar disorder.

ClinicalTrials.gov NCT07306468